M. C. Alanin, K. G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients C. Andersen, B.C. Kahl,

Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact C.R. Hansen, T. Pressler, W. Ridderberg, H.K.

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

Gut bacterial microbiota and obesity

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Pneumococcal infection in adults: burden of disease

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Pseudomonas aeruginosa diversity in distinct paediatric patient groups

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

R. Cantón Clinical Microbiology and Infection

Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections

Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

Vector control: a cornerstone in the malaria elimination campaign

D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study Maret L. Maliniak, Arlene A.

A. Oliver, A. Mena Clinical Microbiology and Infection

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates G.A. Tramper-Stranders,

K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld

Previously unknown species of Aspergillus

Systematic review of antibiotic consumption in acute care hospitals

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T. Benfield, F. Espersen,

Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia—a post hoc analysis in 964 prospectively evaluated patients S. Rieg,

Antibacterial drug discovery in the 21st century

P.M. Hawkey Clinical Microbiology and Infection

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Vaccinations against respiratory tract infections at Hajj

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study J. Smit, L.E. López-Cortés,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Sanford Chodosh Clinical Microbiology and Infection

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

Survival of rhinoviruses on human fingers

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

A. Manzur, F. Gudiol Clinical Microbiology and Infection

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

B.A. Cunha Clinical Microbiology and Infection

C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia M.C. Alanin, K.G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N. Høiby, H.K. Johansen Clinical Microbiology and Infection Volume 21, Issue 12, Pages 1093.e1-1093.e7 (December 2015) DOI: 10.1016/j.cmi.2015.08.020 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Percentage of positive samples with Pseudomonas aeruginosa, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis and Achromobacter xylosoxidans in patients with primary ciliary dyskinesia according to age group. Patients were followed from 2002 to 2012. Children: 0–12 years, n = 62; teenagers and young adults: 13–25 years, n = 54; adults >25 years, n = 38. A patient can appear in more than one age group. *p <0.05. Clinical Microbiology and Infection 2015 21, 1093.e1-1093.e7DOI: (10.1016/j.cmi.2015.08.020) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Lexis diagram showing the course of Pseudomonas aeruginosa infection in 42 patients with primary ciliary dyskinesia who qualified as chronically infected at least once between 2002 and 2012. Courses are displayed from the first evaluable sample until the last observation in 2012. All but one patient (small dots) was evaluable. Chronic infection was based on modified ‘Cystic Fibrosis Leeds criteria’. Clinical Microbiology and Infection 2015 21, 1093.e1-1093.e7DOI: (10.1016/j.cmi.2015.08.020) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions